Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Assets (2020 - 2025)

Rani Therapeutics Holdings (RANI) has 6 years of Assets data on record, last reported at $10.1 million in Q3 2025.

  • For Q3 2025, Assets fell 76.71% year-over-year to $10.1 million; the TTM value through Sep 2025 reached $10.1 million, down 76.71%, while the annual FY2024 figure was $36.6 million, 36.75% down from the prior year.
  • Assets reached $10.1 million in Q3 2025 per RANI's latest filing, down from $16.9 million in the prior quarter.
  • Across five years, Assets topped out at $137.0 million in Q3 2021 and bottomed at $10.1 million in Q3 2025.
  • Average Assets over 5 years is $72.8 million, with a median of $73.9 million recorded in 2021.
  • Peak YoY movement for Assets: surged 56.4% in 2021, then tumbled 76.71% in 2025.
  • A 5-year view of Assets shows it stood at $124.2 million in 2021, then decreased by 13.03% to $108.0 million in 2022, then tumbled by 46.39% to $57.9 million in 2023, then plummeted by 36.75% to $36.6 million in 2024, then crashed by 72.32% to $10.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets were $10.1 million in Q3 2025, $16.9 million in Q2 2025, and $24.1 million in Q1 2025.